News and Press Releases

Contact Veristat Now


Request A Proposal

Contact Us

Veristat Helps Antibe Therapeutics Complete Their Phase IIB Study During COVID-19

May 5, 2020

In early 2019, Veristat helped Antibe Therapeutics, a biotech company with a drug platform of game-changing therapeutics in pain and inflammation, initiate the second part of their phase 2B dose-ranging, efficacy study for ATB-346. To date, this is one of the largest studies completed in Canada consisting of 360 patients with osteoarthritis (“OA”) of the knee, across 40 clinical sites.   

Read More